Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|June 14, 2018
Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classificationAnna Szumera-Ciećkiewicz, Grzegorz Rymkiewicz, Beata Grygalewicz, et al.
Chest|August 9, 2021
Giant Intrathoracic Mass in a Young Woman With Acute Kidney InjuryAnna Matyjek, Olga Stanowska, Lukasz Talarek, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|October 6, 2006
Transformation in lymphomas--morphological, immunophenotypic and molecular featuresMonika Prochorec-Sobieszek, Mirosław Majewski, Anna Sikorska, et al.
Cells|March 1, 2020
CD4+FOXP3+ T Cells in Rheumatoid Arthritis Bone Marrow Are Partially ImpairedMagdalena Massalska, Anna Radzikowska, Ewa Kuca-Warnawin, et al.
Journal of Clinical Medicine|July 2, 2021
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma PatientsJoanna Barankiewicz, Anna Szumera-Ciećkiewicz, Aleksander Salomon-Perzyński, et al.
American Journal of Cancer Research|November 16, 2022
Evidence supporting the oncogenic role of BAZ1B in colorectal cancerAleksandra Grochowska, Malgorzata Statkiewicz, Maria Kulecka, et al.
Archivum Immunologiae Et Therapiae Experimentalis|March 29, 2011
The patterns of MHC association in aplastic and non-aplastic paroxysmal nocturnal hemoglobinuriaJacek Nowak, Renata Mika-Witkowska, Ewa Mendek-Czajkowska, et al.
Genes, Chromosomes & Cancer|January 27, 2015
Human leukocyte antigen-G polymorphisms influence the clinical outcome in diffuse large B-cell lymphomaMarta Bielska, Marcin Bojo, Gabriela Klimkiewicz-Wojciechowska, et al.
Arthritis Research & Therapy|December 9, 2017
Rheumatoid arthritis bone marrow environment supports Th17 responseEwa Kuca-Warnawin, Weronika Kurowska, Monika Prochorec-Sobieszek, et al.
Anticancer Research|December 8, 2020
EZH2 Expression in Follicular Lymphoma Is Variable and Independent from the Progression of Disease Within 24 Months of First TreatmentAnna Szumera-CieĆkiewicz, Jan Poleszczuk, Ewa Paszkiewicz-Kozik, et al.
Pageof 9